Edition:
India

People: Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

197.05USD
12:34am IST
Change (% chg)

$-0.62 (-0.31%)
Prev Close
$197.67
Open
$197.63
Day's High
$199.99
Day's Low
$196.74
Volume
16,953
Avg. Vol
61,773
52-wk High
$217.11
52-wk Low
$132.75

Nusse, Roeland 

Dr. Roeland Nusse Ph.D. is Independent Director of Bio-Techne Corporation. Dr. Nusse earned a bachelor’s degree in biology from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. He did his postdoctoral fellowship at the University of California, San Francisco. Dr. Nusse has served as Chairman of the Department of Developmental Biology at Stanford University since 2007. Dr. Nusse has been a professor or associate professor in the Department of Developmental Biology at Stanford University and an investigator at the Howard Hughes Medical Institute since 1990. He has also been the chair of the Department of Developmental Biology at Stanford since 2007. Dr. Nusse was previously at the Netherlands Cancer Institute (Amsterdam, The Netherlands) as a staff scientist and ultimately head of the Department of Molecular Biology. Dr. Nusse was elected to the United States National Academy of Sciences in April 2010. Dr. Nusse was previously named a member of the European Molecular Biology Organization in 1988, a member of the Royal Dutch Academy of Sciences in 1997 and a member of the American Academy of Arts and Sciences in 2001.

Basic Compensation

Total Annual Compensation, USD 62,500
Restricted Stock Award, USD 92,488
Long-Term Incentive Plans, USD --
All Other, USD 93,579
Fiscal Year Total, USD 248,567

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Baumgartner

298,567

Charles Kummeth

9,076,890

James Hippel

2,226,770

Brenda Furlow

754,004

David Eansor

1,347,200

Robert Gavin

1,215,240
As Of  30 Jun 2017